Association between anatomical resolution and functional outcomes in the mivi-trust studies using ocriplasmin to treat symptomatic vitreomacular adhesion/vitreomacular traction, including when associated with macular hole. [electronic resource]
Producer: 20151104Description: 1151-7 p. digitalISSN:- 1539-2864
- Double-Blind Method
- Eye Diseases -- diagnosis
- Fibrinolysin -- adverse effects
- Fibrinolytic Agents -- adverse effects
- Follow-Up Studies
- Humans
- Intravitreal Injections
- Peptide Fragments -- adverse effects
- Retinal Diseases -- diagnosis
- Retinal Perforations -- diagnosis
- Sickness Impact Profile
- Surveys and Questionnaires
- Tissue Adhesions -- drug therapy
- Visual Acuity -- physiology
- Vitreous Body -- drug effects
No physical items for this record
Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.